Factor XIII

Human Factor XIIIa, Thrombin activated

(hFXIIIa, A subunit, recombinantly produced in insect cells)
Quantity Unit Price Status
200 µg 550 € Available
1 mg 2100 € Available
Documents
Art. No.
T070
Synonym
Recombinant Fibrin stabilizing factor, protein-glutamine-γ-glutamyltransferase
Molecular Weight
79 kDa (monomer); 158 kDa (homodimer)
Source
Recombinantly produced in insect cells.
Activated by human Thrombin
Purity
> 95% [by SDS-PAGE]
Appearance
White lyophilized solid.
Description
Recombinant human Factor XIII is a homodimer (A2) composed of two chains held together by non covalent bonds. After activation of the zymogen by Thrombin and Ca2+ to its active form (Factor XIIIa), Factor XIIIa catalyzes the formation of covalent bridges (ε-(γ-glutamyl) lysine bonds) between fibrin units to increase the elasticity of the clot network. The resulting cross linked fibrin is insoluble and resistant to lysis.
Reconstitution
Add the volume of water specified in the certificate of analysis under aliquotation to the vial of lyophilized powder. Rotate vial gently until solid dissolves. After reconstitution the solution should be stored frozen in working aliquots. For short term storage keep cooled on ice.
Application
hFXIIIa catalyzes acyl transfer reactions from glutamine residues in proteins or peptides to primary amines, e. g. the formation of ε-(γ-glutamyl) lysine bonds between proteins by transferring the acyl group of a peptide-bound glutamine residue to the primary amino group of a peptide-bound lysine residue.
Storage
Store at -80°C. If storage at -80°C is not possible, storage at ≤ -20°C is recommended. While no formal stability data are available at -20°C, according to our overall experience stability is still given. Upon reconstitution, store undiluted working aliquots preferably at -80°C (if not possible at ≤ -20°C, see comment above). Storage of diluted aliquots may result in severe activity loss. Avoid repeated freezing and thawing. Delivery at ambient temperature is possible
Reference(s)
Chrobok et al., PLoS One. 2018, 13:e0196433; Akbar et al., J. Med. Chem. 2017, 60:7910-27; de Jager, M. et al., Neuropathol. Appl. Neurobiol. 2016, 42, 255; Hamedani et al., Chem. Commun. 2015, 51, 1135-39; Böhm et al., J. Med. Chem. 2014, 57, 10355-65
Note
INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.

News

Blog

Events